Tesamorelin Storage Temperature: Lyophilized vs Reconstituted
How tesamorelin storage temperature requirements differ between lyophilized powder and reconstituted solution, and why listings specify separate ranges.
Tesamorelin storage temperature requirements are not a single number. Listings and reference sheets consistently draw a line between the lyophilized (freeze-dried) powder form and the reconstituted liquid form, because the two states have different stability characteristics once bacteriostatic water enters the vial. Understanding tesamorelin storage temperature guidance for each state explains why a vial’s handling instructions change the moment it is mixed.
Why the Two States Differ
A lyophilized peptide is water-free. Freeze-drying removes the solvent that would otherwise let a peptide chain unfold, aggregate, or hydrolyze, so the molecule sits in a comparatively stable solid lattice. That stability is the reason lyophilized tesamorelin vials are typically described as suitable for cold or frozen storage over longer stretches of time, with refrigeration cited most often on supplier documentation.
Reconstitution changes that picture. Once bacteriostatic water is added, the peptide is dissolved in an aqueous environment, which is where most degradation pathways for peptides actually occur: hydrolysis of the peptide backbone, oxidation, and gradual loss of structural integrity all proceed faster in solution than in a dry powder. This is standard peptide chemistry, not specific to tesamorelin, but it is the reason reconstituted tesamorelin vial listings consistently name a shorter storage window and a stricter temperature range than the lyophilized form of the same vial.
Lyophilized Storage: What Listings Typically Specify
Reference sheets for lyophilized tesamorelin generally describe refrigerated storage, with some manufacturer documentation citing freezer storage as an option for extended periods before the vial is opened. The unifying theme across listings is protection from heat, light, and humidity:
- Refrigeration (roughly 2-8°C) is the most commonly cited range for lyophilized vials awaiting reconstitution.
- Freezer storage is sometimes listed as an option for unopened lyophilized vials over a longer horizon, per manufacturer documentation.
- Vials are typically described as light-protected, since amber glass or an opaque secondary container is standard packaging for lyophilized peptides.
- Room-temperature stability is generally described as short-term only, for brief handling or shipping windows rather than storage.
The exact figures vary by manufacturer, which is why a listing’s own documentation, rather than a generic peptide-storage rule, is the reference point for a specific vial.
Reconstituted Storage: What Changes
After bacteriostatic water is added, listings consistently narrow both the temperature range and the storage duration. Refrigeration is described as necessary rather than optional, and freezing a reconstituted solution is generally discouraged on supplier documentation, since freeze-thaw cycling introduces its own stress on dissolved peptides. The comparison below reflects how listings commonly frame the two states side by side.
| Factor | Lyophilized (unmixed) | Reconstituted (mixed) |
|---|---|---|
| Typical temperature range cited | Refrigerated, sometimes frozen | Refrigerated only |
| Duration commonly cited | Longer-term, per expiration date | Shorter window, per listing |
| Freezing | Sometimes listed as an option | Generally discouraged |
| Light exposure | Protected, amber vial standard | Protected, same vial |
| Primary degradation concern | Minimal in dry state | Hydrolysis and oxidation in solution |
How Reconstitution Volume Relates to Storage Discussions
Storage guidance is often discussed alongside reconstitution because the two are documented together on the same product insert. A vial listed at, for example, 2 mg of tesamorelin reconstituted with 2 mL of bacteriostatic water yields a solution concentration of 1 mg/mL (2 mg ÷ 2 mL = 1 mg/mL). Converting to a U-100 insulin syringe scale, where 1 mL equals 100 units, that 1 mg/mL solution maps to 1 mg per 100 units, or 10 mcg per unit (1 mg = 1000 mcg, so 1000 mcg ÷ 100 units = 10 mcg/unit). None of these figures describe how the solution should be used; they describe how a listing’s concentration math is derived, which is the same math that determines how much diluent volume is sitting in the vial for the duration of its reconstituted storage window. Readers cross-checking dilution math against a specific vial size can verify the arithmetic with an independent tool such as peptcalc.com rather than relying on a single source.
Reading a Listing’s Storage Instructions Correctly
A tesamorelin listing’s storage section is describing conditions for that specific manufacturer’s formulation and packaging, not a universal peptide standard. Cross-referencing several listings in the same cluster, such as the storage and stability overview at tesamorelincost.com, shows how consistently the lyophilized-versus-reconstituted distinction appears across independent sources, which is a useful check when a single listing’s documentation is thin. When sourcing information, checking whether a vendor provides a certificate of analysis, such as the documentation available through a COA-verified source, helps confirm that the storage guidance printed on a listing traces back to actual testing on that batch rather than a copied template.
Common Points of Confusion
Several details get conflated in casual discussion of tesamorelin storage temperature:
- “Room temperature stable” claims on lyophilized listings usually refer to brief shipping windows, not indefinite storage.
- A shorter reconstituted storage window is a property of the solution state, not a sign that a particular vial was mishandled.
- Freezing a reconstituted vial is different from freezing the lyophilized powder; listings that permit the latter rarely permit the former.
- Storage duration figures on a listing describe that manufacturer’s testing, not a chemistry constant that applies identically to every source.
Summary
Tesamorelin storage temperature guidance splits cleanly along the line between lyophilized powder and reconstituted solution. The dry form is generally described as refrigerator- or freezer-stable over longer periods, while the reconstituted form is consistently narrowed to refrigeration only and a shorter usable window, reflecting the faster degradation pathways available once the peptide is in aqueous solution. Reading a listing’s own storage section, alongside its reconstitution math and any available certificate of analysis, is the most reliable way to understand what a specific vial actually requires.
A note on how to read this
This article is written for research and educational reference. The materials described are sold for laboratory research and are not for human consumption. Nothing here is dosing guidance, a prescription, or a clinical recommendation.